+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 6ich | ||||||
---|---|---|---|---|---|---|---|
タイトル | Grb2 SH2 domain in domain swapped dimer form | ||||||
要素 | Growth factor receptor-bound protein 2 | ||||||
キーワード | SIGNALING PROTEIN / Src homology 2 domain / phosphorylated tyrosine / Adapter protein | ||||||
機能・相同性 | 機能・相同性情報 guanyl-nucleotide exchange factor adaptor activity / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / STAT5 Activation / COP9 signalosome / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity / Signaling by cytosolic FGFR1 fusion mutants ...guanyl-nucleotide exchange factor adaptor activity / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / STAT5 Activation / COP9 signalosome / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity / Signaling by cytosolic FGFR1 fusion mutants / Interleukin-15 signaling / MET activates PTPN11 / MET activates RAP1 and RAC1 / vesicle membrane / Costimulation by the CD28 family / CD28 dependent Vav1 pathway / Signaling by LTK / MET activates PI3K/AKT signaling / Signal regulatory protein family interactions / natural killer cell mediated cytotoxicity / positive regulation of actin filament polymerization / epidermal growth factor receptor binding / Regulation of KIT signaling / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR3 / STAT5 activation downstream of FLT3 ITD mutants / PI-3K cascade:FGFR4 / PI-3K cascade:FGFR1 / endodermal cell differentiation / regulation of MAPK cascade / GRB2:SOS provides linkage to MAPK signaling for Integrins / RHOU GTPase cycle / PI3K events in ERBB2 signaling / PI3K Cascade / RET signaling / SOS-mediated signalling / insulin receptor substrate binding / Activated NTRK3 signals through RAS / Interleukin-3, Interleukin-5 and GM-CSF signaling / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / fibroblast growth factor receptor signaling pathway / Signalling to RAS / signal transduction in response to DNA damage / RHO GTPases Activate WASPs and WAVEs / GAB1 signalosome / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / Role of LAT2/NTAL/LAB on calcium mobilization / Interleukin receptor SHC signaling / Signal attenuation / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / Schwann cell development / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / Erythropoietin activates RAS / Signaling by CSF3 (G-CSF) / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR2 signaling / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / Signaling by FGFR2 in disease / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / Tie2 Signaling / FRS-mediated FGFR1 signaling / GRB2 events in EGFR signaling / FLT3 Signaling / SHC1 events in EGFR signaling / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / phosphotyrosine residue binding / Signaling by FGFR1 in disease / myelination / ephrin receptor binding / GRB2 events in ERBB2 signaling / NCAM signaling for neurite out-growth / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / FCERI mediated Ca+2 mobilization / insulin-like growth factor receptor signaling pathway / T cell activation / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / InlB-mediated entry of Listeria monocytogenes into host cell / Antigen activates B Cell Receptor (BCR) leading to generation of second messengers / Regulation of signaling by CBL / cellular response to ionizing radiation / Negative regulation of FGFR2 signaling / FCGR3A-mediated phagocytosis / FCERI mediated MAPK activation / Negative regulation of FGFR3 signaling / B cell receptor signaling pathway / Signaling by ERBB2 TMD/JMD mutants / EGFR downregulation 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 2 Å | ||||||
データ登録者 | Hosoe, Y. / Numoto, N. / Inaba, S. / Ogawa, S. / Morii, H. / Abe, R. / Ito, N. / Oda, M. | ||||||
引用 | ジャーナル: Biophys Physicobio. / 年: 2019 タイトル: Structural and functional properties of Grb2 SH2 dimer in CD28 binding. 著者: Hosoe, Y. / Numoto, N. / Inaba, S. / Ogawa, S. / Morii, H. / Abe, R. / Ito, N. / Oda, M. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 6ich.cif.gz | 36 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb6ich.ent.gz | 21.1 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 6ich.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 6ich_validation.pdf.gz | 416.7 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 6ich_full_validation.pdf.gz | 416.6 KB | 表示 | |
XML形式データ | 6ich_validation.xml.gz | 6.1 KB | 表示 | |
CIF形式データ | 6ich_validation.cif.gz | 7.5 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ic/6ich ftp://data.pdbj.org/pub/pdb/validation_reports/ic/6ich | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 10998.404 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: GRB2, ASH / プラスミド: pGEX-4T-1 / 発現宿主: Escherichia coli BL21(DE3) (大腸菌) / 参照: UniProt: P62993 |
---|---|
#2: 水 | ChemComp-HOH / |
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 2.74 Å3/Da / 溶媒含有率: 55.08 % |
---|---|
結晶化 | 温度: 293 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 6.5 / 詳細: 0.1 M MES monohydrate (pH 6.5), 12% PEG 20,000 |
-データ収集
回折 | 平均測定温度: 90 K |
---|---|
放射光源 | 由来: シンクロトロン / サイト: Photon Factory / ビームライン: BL-5A / 波長: 1 Å |
検出器 | タイプ: ADSC QUANTUM 315 / 検出器: CCD / 日付: 2016年5月16日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1 Å / 相対比: 1 |
反射 | 解像度: 2→50 Å / Num. obs: 8418 / % possible obs: 99.9 % / 冗長度: 14.1 % / Biso Wilson estimate: 37.24 Å2 / CC1/2: 1 / Rsym value: 0.058 / Net I/σ(I): 30.4 |
反射 シェル | 解像度: 2→2.12 Å / 冗長度: 14.2 % / Mean I/σ(I) obs: 4 / Num. unique obs: 1323 / CC1/2: 0.923 / Rsym value: 0.845 / % possible all: 99.8 |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 開始モデル: 3WA4 解像度: 2→30.89 Å / SU ML: 0.2285 / 交差検証法: FREE R-VALUE / σ(F): 1.35 / 位相誤差: 32.5939
| ||||||||||||||||||||||||||||
溶媒の処理 | 減衰半径: 0.9 Å / VDWプローブ半径: 1.11 Å | ||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 45.64 Å2 | ||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2→30.89 Å
| ||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||
LS精密化 シェル |
|